Rockwell Medical Inc
NASDAQ:RMTI

Watchlist Manager
Rockwell Medical Inc Logo
Rockwell Medical Inc
NASDAQ:RMTI
Watchlist
Price: 2.13 USD -4.48%
Market Cap: 68.8m USD
Have any thoughts about
Rockwell Medical Inc?
Write Note

Rockwell Medical Inc
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Rockwell Medical Inc
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Rockwell Medical Inc
NASDAQ:RMTI
Current Portion of Long-Term Debt
$587k
CAGR 3-Years
-56%
CAGR 5-Years
N/A
CAGR 10-Years
-23%
Haemonetics Corp
NYSE:HAE
Current Portion of Long-Term Debt
$5.4m
CAGR 3-Years
-60%
CAGR 5-Years
-37%
CAGR 10-Years
12%
ICU Medical Inc
NASDAQ:ICUI
Current Portion of Long-Term Debt
$52m
CAGR 3-Years
343%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Align Technology Inc
NASDAQ:ALGN
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Lantheus Holdings Inc
NASDAQ:LNTH
Current Portion of Long-Term Debt
$564.7m
CAGR 3-Years
279%
CAGR 5-Years
123%
CAGR 10-Years
N/A
Merit Medical Systems Inc
NASDAQ:MMSI
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Rockwell Medical Inc
Glance View

Market Cap
68.8m USD
Industry
Health Care

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. The company is headquartered in Wixom, Michigan and currently employs 300 full-time employees. The firm is developing and commercializing its technology platform, Ferric Pyrophosphate Citrate (FPC) for the transformative treatments for iron deficiency in multiple disease states. The company is also a supplier of hemodialysis concentrate products to kidney dialysis clinics. The firm has developed therapies namely Triferic and Triferic AVNU from its FPC platform. The Company’s products from its FPC platform, Triferic (dialysate) and Triferic AVNU intravenous (IV), is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients. Its Triferic AVNU, is an IV formulation of Triferic, for use by hemodialysis patients. its dialysis concentrates products include CitraPure Citric Acid Concentrate, Dri-Sate Dry Acid Concentrate, RenalPure Liquid Acid Concentrate, Dry Acid Concentrate Mixer, RenalPure and SteriLyte Bicarbonate Concentrate and Ancillary products.

RMTI Intrinsic Value
1.23 USD
Overvaluation 42%
Intrinsic Value
Price

See Also

What is Rockwell Medical Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
587k USD

Based on the financial report for Sep 30, 2024, Rockwell Medical Inc's Current Portion of Long-Term Debt amounts to 587k USD.

What is Rockwell Medical Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
-23%

Over the last year, the Current Portion of Long-Term Debt growth was -91%. The average annual Current Portion of Long-Term Debt growth rates for Rockwell Medical Inc have been -56% over the past three years , and -23% over the past ten years .

Back to Top